Package 42291-958-30

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 42291-958-30
Digits Only 4229195830
Product NDC 42291-958
Product ID 42291-958_48c104bb-d8d9-2940-e063-6394a90aeab3
Description

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-958-30)

Marketing

Marketing Status
Marketed Since 2024-10-30
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Topiramate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c104bb-d8d9-2940-e063-6394a90aeab3", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0342291958302", "0342291957305", "0342291956308"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1437278", "1437283", "1437288"], "spl_set_id": ["25b377f7-ea89-fb56-e063-6394a90a239d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-958-30)", "package_ndc": "42291-958-30", "marketing_start_date": "20241030"}], "brand_name": "Topiramate", "product_id": "42291-958_48c104bb-d8d9-2940-e063-6394a90aeab3", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "42291-958", "generic_name": "Topiramate", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA206210", "marketing_category": "ANDA", "marketing_start_date": "20241030", "listing_expiration_date": "20271231"}